VNS Algorithm for Advanced Dosing

Recruiting now · Not applicable

Conditions studied: Epilepsies

In brief

The goal of this clinical trial is to compare the standard programming of the VNS device (Control) to a modified programming (Augusta Way) in adults with epilepsy. The main question it aims to answer is: Does the modified programming of the VNS reduce seizures faster than the standard programming? Participants in both groups will: 1. Attend up to 3 study visits every 3 months for 2 years 2. Answer questionnaires to assess quality of life and cognitive function 3. Maintain a diary of seizure activity

Key facts

Study ID

NCT07725601

Run by

Fernando Vale

People needed

80

Starts

2025-08-01

Expected to finish

2030-12-30

Last updated by the study team

2026-07-24

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who are clinically determined to be candidates for VNS implantation for seizure control
• Subject/legally authorized representative able to provide informed consent.

You may not qualify if…

• Subjects with VNS system treating pathologies other than drug refractory epilepsy or medical co-morbidities that prevent any surgical intervention

Where it is running

• Wellstar MCG Hospital — Augusta, Georgia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.